• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dispositional hope as a potential outcome parameter among patients with advanced malignancy: An analysis of the ENABLE database.晚期恶性肿瘤患者的特质希望作为潜在结局参数:ENABLE 数据库分析。
Cancer. 2022 Jan 15;128(2):401-409. doi: 10.1002/cncr.33907. Epub 2021 Oct 6.
2
Associations between advanced cancer patients' survival and family caregiver presence and burden.晚期癌症患者的生存与家庭照顾者的陪伴及负担之间的关联。
Cancer Med. 2016 May;5(5):853-62. doi: 10.1002/cam4.653. Epub 2016 Feb 10.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
The Project ENABLE Cornerstone randomized controlled trial: study protocol for a lay navigator-led, early palliative care coaching intervention for African American and rural-dwelling advanced cancer family caregivers.项目 ENABLE 基石随机对照试验:一项针对非裔美国人和农村地区晚期癌症家庭照顾者的由外展员主导的、早期姑息治疗辅导干预的研究方案。
Trials. 2022 Jun 2;23(1):452. doi: 10.1186/s13063-022-06305-w.
5
Early palliative care for adults with advanced cancer.晚期癌症成年患者的早期姑息治疗。
Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.
6
Effects of a Telehealth Early Palliative Care Intervention for Family Caregivers of Persons With Advanced Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.远程医疗早期姑息治疗对晚期心力衰竭患者家属的影响:ENABLE CHF-PC 随机临床试验。
JAMA Netw Open. 2020 Apr 1;3(4):e202583. doi: 10.1001/jamanetworkopen.2020.2583.
7
Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.早期姑息治疗远程医疗干预与常规护理对心力衰竭患者的影响:ENABLE CHF-PC 随机临床试验。
JAMA Intern Med. 2020 Sep 1;180(9):1203-1213. doi: 10.1001/jamainternmed.2020.2861.
8
The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.针对患有晚期疾病的成年人及其护理人员的医院专科姑息治疗的有效性和成本效益。
Cochrane Database Syst Rev. 2020 Sep 30;9(9):CD012780. doi: 10.1002/14651858.CD012780.pub2.
9
The role of a palliative care intervention in moderating the relationship between depression and survival among individuals with advanced cancer.姑息治疗干预在调节晚期癌症患者抑郁与生存之间关系中的作用。
Health Psychol. 2017 Dec;36(12):1140-1146. doi: 10.1037/hea0000544. Epub 2017 Oct 19.
10
Using Patients and Their Caregivers Feedback to Develop ENABLE CHF-PC: An Early Palliative Care Intervention for Advanced Heart Failure.利用患者及其护理人员的反馈来开发ENABLE CHF-PC:一种针对晚期心力衰竭的早期姑息治疗干预措施。
J Palliat Care. 2019 Apr;34(2):103-110. doi: 10.1177/0825859718785231. Epub 2018 Jun 28.

引用本文的文献

1
"I hope to get some hope": balancing expectations, hope, and acceptance in naturally occurring consultations without a medical diagnosis.“我希望获得一些希望”:在未确诊的自然咨询中平衡期望、希望与接纳。
Int J Qual Stud Health Well-being. 2025 Dec;20(1):2554486. doi: 10.1080/17482631.2025.2554486. Epub 2025 Sep 2.
2
Living with brain metastasis - a qualitative study of patients' and family members' coping strategies.与脑转移共存——对患者及其家庭成员应对策略的定性研究
Int J Qual Stud Health Well-being. 2025 Dec;20(1):2555228. doi: 10.1080/17482631.2025.2555228. Epub 2025 Sep 1.
3
Interaction effect of comorbid depression and proactive positivity coping strategy on the 1-year survival of patients with advanced cancer: a nationwide multicentre study in South Korea.共病抑郁症与积极应对策略对晚期癌症患者1年生存率的交互作用:韩国一项全国性多中心研究
BMC Psychiatry. 2025 Jun 2;25(1):565. doi: 10.1186/s12888-025-06972-4.
4
Artificial intelligence and patient narratives: A novel approach to assessing hope in patients with cancer.人工智能与患者叙述:一种评估癌症患者希望的新方法。
Med Int (Lond). 2025 May 7;5(4):41. doi: 10.3892/mi.2025.240. eCollection 2025 Jul-Aug.
5
Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients.抑郁、身体状况和治疗中断会影响可治愈信念与晚期癌症患者预后之间的关联。
Sci Rep. 2024 Nov 24;14(1):29098. doi: 10.1038/s41598-024-80687-6.
6
Tipping Point: Pathogenic Stress and the Biopolitics of Euthanasia.临界点:致病性压力与安乐死的生命政治
Linacre Q. 2024 Oct 18:00243639241287918. doi: 10.1177/00243639241287918.
7
Cultural and social barriers to hope in gastrointestinal cancer patients.胃肠道癌症患者希望的文化和社会障碍。
J Gastrointest Oncol. 2024 Aug 31;15(4):1487-1496. doi: 10.21037/jgo-23-938. Epub 2024 Aug 23.
8
Mindfulness-based psychosocial interventions and psychological wellbeing in cancer survivorship: a meta-analysis.基于正念的心理社会干预和癌症生存者的心理幸福感:一项荟萃分析。
Health Psychol Rev. 2024 Dec;18(4):723-749. doi: 10.1080/17437199.2024.2336014. Epub 2024 Apr 1.
9
"Pathways": A hope-enhancing intervention for patients undergoing treatment for advanced lung cancer."Pathways":一种针对晚期肺癌治疗患者的希望增强干预措施。
Psychooncology. 2024 Mar;33(3):e6316. doi: 10.1002/pon.6316.
10
The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients.希望的生物学:卵巢癌患者的炎症和神经内分泌特征。
Brain Behav Immun. 2024 Feb;116:362-369. doi: 10.1016/j.bbi.2023.12.014. Epub 2023 Dec 9.

本文引用的文献

1
The science of hope.希望的科学。
Lancet Oncol. 2020 Sep;21(9):e452-e459. doi: 10.1016/S1470-2045(20)30210-2.
2
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.每日短信和直接监督治疗干预对急性淋巴细胞白血病儿童口服巯嘌呤依从性的影响:一项随机临床试验。
JAMA Netw Open. 2020 Aug 3;3(8):e2014205. doi: 10.1001/jamanetworkopen.2020.14205.
3
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.随机试验:短信对减少早期乳腺癌女性辅助芳香酶抑制剂治疗早期停药的影响:SWOG S1105。
J Clin Oncol. 2020 Jul 1;38(19):2122-2129. doi: 10.1200/JCO.19.02699. Epub 2020 May 5.
4
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.2009-2018 年新药推向市场所需的研发投资估算。
JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166.
5
Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis.吸烟暴露与新辅助化疗反应及根治性膀胱切除术后生存结局的关系:系统评价和荟萃分析。
J Urol. 2020 Oct;204(4):649-660. doi: 10.1097/JU.0000000000000813. Epub 2020 Feb 27.
6
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
7
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.纳武利尤单抗对比化疗用于既往化疗后进展或不耐受的晚期食管鳞癌患者(ATTRACTION-3):一项多中心、随机、开放标签、III 期临床研究。
Lancet Oncol. 2019 Nov;20(11):1506-1517. doi: 10.1016/S1470-2045(19)30626-6. Epub 2019 Sep 30.
8
Encorafenib, Binimetinib, and Cetuximab in V600E-Mutated Colorectal Cancer.encorafenib、binimetinib 和西妥昔单抗治疗 V600E 突变型结直肠癌。
N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30.
9
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.体力活动与转移性结直肠癌患者生存和进展的相关性:癌症和白血病组 B(联盟)/SWOG80405 的研究结果。
J Clin Oncol. 2019 Oct 10;37(29):2620-2631. doi: 10.1200/JCO.19.01019. Epub 2019 Aug 13.
10
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.阿替利珠单抗作为转移性非鳞状 NSCLC 一线治疗药物。
N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4.

晚期恶性肿瘤患者的特质希望作为潜在结局参数:ENABLE 数据库分析。

Dispositional hope as a potential outcome parameter among patients with advanced malignancy: An analysis of the ENABLE database.

机构信息

Department of Oncology, Shaare Zedek Cancer Center, Jerusalem, Israel.

Department of Counseling Psychology, Santa Clara University, Santa Clara, California.

出版信息

Cancer. 2022 Jan 15;128(2):401-409. doi: 10.1002/cncr.33907. Epub 2021 Oct 6.

DOI:10.1002/cncr.33907
PMID:34613617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10008020/
Abstract

BACKGROUND

Hopefulness, whether inherently present (dispositional hope) or augmented (by enhancement techniques), may affect outcomes. This study was performed to determine the association of dispositional hope with survival among patients diagnosed with advanced cancer.

METHODS

Data from ENABLE (Educate, Nurture, Advise, Before Life Ends), a palliative care intervention, were reanalyzed to determine the association of higher dispositional hope and patient survival. This was a secondary analysis of data combined from the ENABLE II and ENABLE III randomized controlled trials (RCTs) with respect to dispositional hope and survival. A dispositional hope index was created from 3 hope items from 2 validated baseline questionnaires. Dispositional hope and survival data were collected during the 2 RCTs. In ENABLE II, participants were randomly assigned to the ENABLE intervention or to usual care. In ENABLE III, participants were randomly assigned to receive the intervention immediately or 12 weeks after enrollment.

RESULTS

In all, 529 persons were included in Cox proportional hazards regression analyses to model the effects of dispositional hope on survival. An initial analysis without covariates yielded a significant effect of hope (Wald statistic, 8.649; hazard ratio, 0.941; confidence interval, 0.904-0.980; P = .003), such that higher dispositional hope was associated with longer survival. In a subsequent analysis that included all covariates, the effect of dispositional hope approached statistical significance (Wald statistic, 2.96; hazard ratio, 0.933; confidence interval, 0.863-1.010; P = .085).

CONCLUSIONS

Higher levels of dispositional hope were associated with longer survival in patients with advanced cancer. Prospective trials are needed to determine the effects of dispositional and augmented hope on the outcomes of patients with advanced cancer.

摘要

背景

希望无论是固有存在的(特质性希望)还是通过增强技术增强的,都可能影响结局。本研究旨在确定特质性希望与诊断为晚期癌症患者的生存之间的关系。

方法

对姑息治疗干预措施 ENABLE 研究的数据进行了重新分析,以确定特质性希望与患者生存之间的关系。这是对来自 ENABLE II 和 ENABLE III 随机对照试验(RCT)中特质性希望和生存数据的二次分析。特质性希望指数是由 2 个经过验证的基线问卷中的 3 个希望项目创建的。特质性希望和生存数据是在这 2 个 RCT 中收集的。在 ENABLE II 中,参与者被随机分配到 ENABLE 干预组或常规护理组。在 ENABLE III 中,参与者被随机分配到立即接受干预或在入组后 12 周接受干预。

结果

共有 529 人被纳入 Cox 比例风险回归分析模型,以评估特质性希望对生存的影响。在没有协变量的初始分析中,希望具有显著的效果(Wald 统计量,8.649;风险比,0.941;置信区间,0.904-0.980;P =.003),即特质性希望越高,生存时间越长。在包含所有协变量的后续分析中,特质性希望的作用接近统计学意义(Wald 统计量,2.96;风险比,0.933;置信区间,0.863-1.010;P =.085)。

结论

在晚期癌症患者中,特质性希望水平越高,生存时间越长。需要前瞻性试验来确定特质性和增强性希望对晚期癌症患者结局的影响。